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Targeted pH switched europium complexes
monitoring receptor internalisation in living cells†
Jack D. Fradgley,a Matthieu Starck, a Michel Laget,b Emmanuel Bourrier,b
Elodie Dupuis,b Laurent Lamarque,b Eric Trinquet,b Jurriaan M. Zwierb and
David Parker *a
We report the design and evaluation of pH responsive luminescent
europium(III) probes that allow conjugation to targeting vectors to
monitor receptor internalisation in cells. The approach adopted
here can be used to tag proteins selectively and to monitor uptake
into more acidic organelles, thereby enhancing the performance of
time-resolved internalisation assays that require pH monitoring in
real time.
During the ageing process of endosomes and phagosomes, the
pH tends to reduce with time and endosomes eventually may
evolve into lysosomes. The cytosolic pH of healthy cells is
around 7.2, whereas endosomal pH varies from 6.5 to 5.5; in
mature lysosomes the pH is typically around 4.5. Receptor
internalisation and endosomal uptake1 can be monitored pro-
vided that the species that is internalised (receptor or substrate)
is labelled with a pH sensitive dye, whose emission intensity or
lifetime varies significantly with pH.2–5
Recently, we have identified europium(III) complexes that
show a pH dependent change in lifetime of a factor of 3 and an
emission intensity pH switching ratio of around two orders of
magnitude, using time-gated acquisition methods.6 Each of
these Eu(III) complexes is C3 symmetric and contains strongly
absorbing alkynyl-aryl chromophores, e.g. EuL1a with a bright-
ness of 10 200 M1 cm1 (332 nm) in acidic conditions. With a
conjugated diethylamino group the pKa value is 6.2 (295 K) and
falls by one unit as a methyl group replaces one of the ethyl
substituents. The absorption spectrum changes with pH
because acidification perturbs the energy of the ligand centred
and internal charge transfer transitions that exist in these
EuroTrackerTM dyes and related series of complexes.7–12
With this background in mind, we set about preparing
complexes suitable for use in cellulo that are hydrophilic and
appropriately substituted to enable conjugation to targeting vec-
tors. Thus, in EuL2a/2b (Scheme S2, ESI†), peripheral sulfonate
groups on the two conjugated chromophores were introduced in
order to minimise non-specific binding of the complex to
proteins.12 In addition, the simple pyridine group was functiona-
lised with a primary amino-propyl group (N-Boc protected), in
order to permit subsequent site-selective conjugation to different
targeting vectors.13 The synthesis of the Eu(III) complexes of L1b
and L2a/2b was undertaken in a similar manner, (Scheme 1 and
Scheme S2, ESI†), from mono-Boc-1,4,7-triazacyclononane. The
syntheses involved a series of N-alkylation and simple deprotection
steps, and the final complexes were purified by reverse phase
HPLC. Under the strongly acidic conditions of the Boc removal
step, protonation of the proximate dialkylamino group inhibits any
unwanted acid catalysed alkyne hydration. Reaction of the mesy-
late 1,6 with mono-Boc-1,4,7-triazacyclononane gave the carbamate
2, followed by treatment with TFA in CH2Cl2 to yield the amine 3.
Alkylation with the disubstituted pyridine mesylate 4,14 afforded
the ester 5, and basic hydrolysis in aqueous methanol followed by
complexation with EuCl3 at pH 6 gave the desired neutral complex,
EuL.1b
The absorption spectrum of EuL2b showed a pH dependence
associated with reversible protonation of the dialkylamino
a Department of Chemistry, Durham University, South Road, Durham DH1 3LE, UK.
E-mail: david.parker@dur.ac.uk
b Cisbio Bioassays, BP 84175, 30200 Codolet, France
† Electronic supplementary information (ESI) available: Ligand and complex
synthesis; photophysical data and spectra; cell experiments. See DOI: 10.1039/
d1cc01029h
Received 23rd February 2021,




























































































View Journal  | View Issue
This journal is © The Royal Society of Chemistry 2021 Chem. Commun., 2021, 57, 5814–5817 |  5815
group that was characterised by the appearance of two isosbes-
tic points at 284 and 332 nm, (Fig. 1). Similar behaviour was
found with the other two complexes (Fig. S1 and S3–S5, ESI†).
In each case, protonation switched on europium luminescence
and the emission lifetime and intensity were measured as a
function of pH (Fig. 2, Tables 1 and 2). Thus, with EuL2a
excitation at the isosbestic point led to an increase in lifetime
from 0.24 (pH 8) to 1.02 ms (pH 4) with a 50-fold increase in
emission intensity (Fig. S6, ESI†). Monitoring changes in emis-
sion lifetime or intensity allowed pKa values to be estimated. In
0.1 M NaCl solution, the N,N-diethyl complexes had similar
values around 6.2, reducing to 5.34 for the N-methylethyl
analogue, EuL2b (Fig. S10–S12, ESI†). These pKa values are
sensitive to the nature of the medium and reduced slightly in
cell lysate solution, highlighting the need to calibrate the pH
dependence in the medium of interest.
In each case, the increases in quantum yield and brightness
(Table 2) following acidification are in accord with a strongly
Scheme 1 Synthesis of complex EuL1b
Fig. 1 pH Variation of the absorbance spectrum of EuL2b (295 K, 0.1 M
NaCl), showing isosbestic points at 284 and 332 nm.
Fig. 2 pH Variation of the europium emission spectrum of EuL2a
(lexc 332 nm, 295 K, c = 20 mM, 0.1 M NaCl); the inset shows the variation
of the europium emission lifetime with pH (lexc 332 nm, lem 613 nm). A pKa
value of 6.18 was estimated by non-linear least squares regression analysis.
Table 1 Summary of pKa values determined for Eu(III) complexes.
a
Complex Conditions pKa
EuL1a 0.1 M NaCl 6.21 (03)
NIH-3T3 cell lysate 5.92 (04)
EuL1b 0.1 M NaCl 6.30 (03)
NIH-3T3 cell lysate 6.25 (04)
EuL2a 0.1 M NaCl 6.18 (03)
NIH-3T3 cell lysate 6.00 (04)
EuL2b 0.1 M NaCl 5.34 (03)
NIH-3T3 cell lysate 5.28 (04)
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emissive and longer-lived protonated complex (see the invar-
iance of the form of the excitation spectra with pH: Fig. S4, S7
and S13, ESI†), wherein the photo-induced electron transfer
process that quenches the europium excited state is sup-
pressed. By varying both the delay time and time window for
signal acquisition, the ‘switch-on’ can be increased, as signal
from the more emissive complex is favoured. For example, by
using a delay time of 1.5 ms and acquiring signal for one
millisecond (1500–2500 ms acquisition period), intensity ratios
for pH 4/pH 8 solutions of around 500 were found (Table 3 and
Fig. 3; Fig. S8/9; Table S1, ESI†), with a progressive diminution
in the apparent pKa value as the delay time was increased.
In a proof-of-concept study for membrane receptor labelling
and trafficking, the benzylguanine (BG) derivative EuL,2c was
prepared from EuL2a using established methodology (Scheme
S3, ESI†).12 The BG derivative serves to label the SNAP-tag (ST),
a self-labelling suicide enzyme15 often used to study G-Protein
Coupled Receptors (GPCRs). Previous studies have shown that
Eu(III)12 and Tb(III) derivatives16,17 can be used to label SNAP
tagged receptors. Using the non-pH sensitive Lumi4-Tb
complex,18 the Tag-lite technologys emerged and Lumi4-Tb
labelled GPCR can be used to signal receptor internalisation.
Therefore, such a model is well suited to test the behaviour of
these new europium pH responsive probes.
The glucagon-like peptide-1 receptor (GLP-1R) is a receptor
targeted for anti-diabetic drugs since it is involved in the
metabolic pathway for insulin production. Tools to study its
agonist-induced internalisation19,20 are therefore in high
demand. After labelling a HEK-293 cell line that stably
expresses GLP-1R-ST with 200 nM of EuL2c at pH 7.4, the Eu
time-gated luminescence was observed (Fig. 4A: 620 nm, DJ = 2
band, pH 4.5, acetate buffer; ESI†). Since labelling to non-
transfected HEK-293 cells is negligible under the same condi-
tions, this demonstrates that labelling of the GLP-1R with EuL2c
on the cell surface is specific, and the compound does not
accumulate in endosomal particles, as this would give rise to an
Table 2 Photophysical properties of the stated Eu(III) complexes (295 K,
0.1 M NaCl)
Complex lexc/nm e/M
1 cm1 t/mse F/%e q B/M1 cm1 f
EuL1a 331 60 000a,d 0.25b 0.1b 0 46b
0.84c 17c 10 200c
EuL1b 328 35 000a 0.34b 0.2a 0 70b
1.00c 18b 6300c
EuL2a 332 39 000a 0.24b 0.3a 0 117b
1.02c 16b 6240c
EuL2b 332 39 000a 0.28b 0.01a 0 4b
1.04c 15b 5850c
a Value at the isosbestic point. b Value at pH = 8. c Value at pH = 4.
d Data from Ref. 6. e Errors in lifetime measurements are 10% and in
quantum yields 15%. f Brightness values are given at the stated
excitation wavelength.
Table 3 Ratios of emission intensities (Irel = ‘switch-on’ factors) for EuL
1b/
EuL2a for differing time gate periods, showing the effect on the apparent
pKa values (295 K, c = 20 mM, 0.1 M NaCl; buffers, NH4OAc (0.1 M, pH 4),
NH4HCO3 (0.1 M, pH 8))
60–460 ms 1000–2000 ms 1500–2500 ms
Irel: pH 4/pH 8 34/32 266/227 527/465
Apparent pKa 6.21/6.57 5.96/6.26 5.86/6.16
Fig. 3 Relative emission intensity of EuL1b (lem 613 nm) as a function of
pH for different time periods of signal acquisition (blue = 60–460 ms, red =
1000–2000 ms, green = 1500–2500 ms). Data are normalised to a 60–460
ms time window at pH 4. Measurements were made in aqueous solutions
of NH4OAc (pH 4 and 5), MES (pH 5.5, 6, 6.5), HEPES (pH 7) and NH4HCO3
(pH 8) buffers (c = 20 mM, 0.1 M buffer in 0.1 M NaCl).
Fig. 4 Time gated measurements of the Eu DJ = 2 band intensity of: (A)
GLP-1R-ST receptor labelling, using EuL2c (200 nM) on non-transfected
and GLP-1R-ST expressing HEK293 cells; (B) GLP-1R-ST receptor inter-
nalisation, 1 h after addition of 100 nM of the peptide agonist, Exendin-4,

























































































This journal is © The Royal Society of Chemistry 2021 Chem. Commun., 2021, 57, 5814–5817 |  5817
observable luminescence signal. As has been shown for related
Eu complexes,12 the introduction of peripheral anionic sulfo-
nate groups in the probe structure suppresses any non-specific
labelling to cells.
To follow receptor internalisation by monitoring endosomal
acidification, 100 nM of the GLP-1R peptide agonist Exendin-4
was added to the EuL2c labelled receptors at pH 7.4. Measuring
the time gated luminescence at 620 nm after a 1 h incubation
revealed a 5-fold increase in luminescence intensity, as a result
of both receptor internalisation and the subsequent endosomal
acidification (Fig. 4B). Further pharmacological studies are
underway on GLP-1R and other membrane receptors to reveal
whether these promising europium pH probes have a bright
future for studying receptor internalisation and its time depen-
dence, both in vitro and in live cell assays.
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